General Information of the Compound
| Compound ID |
CP0470493
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[2-[2-chloro-4-(4-piperidin-1-ylpiperidin-1-yl)pyrrolo[2,3-d]pyrimidin-7-yl]ethyl]morpholine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H33ClN6O
|
||||||||||||||||||
| Molecular Weight |
433
|
||||||||||||||||||
| Canonical SMILES |
Clc1nc(N2CCC(CC2)N2CCCCC2)c2ccn(CCN3CCOCC3)c2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H33ClN6O/c23-22-24-20(28-9-4-18(5-10-28)27-7-2-1-3-8-27)19-6-11-29(21(19)25-22)13-12-26-14-16-30-17-15-26/h6,11,18H,1-5,7-10,12-17H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
DCWDGWVJPVVZDG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Protein ID: PT01711, Histamine H4 receptor